American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: Editor-in-chief: Apply for this position
Open Access
Journal Browser
American Journal of Medical Case Reports. 2020, 8(11), 431-432
DOI: 10.12691/ajmcr-8-11-14
Open AccessCase Report

Coronavirus Presenting With an Urticarial Rash: A Case Report and Literature Review

Kashini Andrew1, , Mohd Bakar1 and Mivanyi Kadala2

1Stroke Medicine, Morriston Hospital, Swansea, Wales

2General Medicine, Northern General Hospital, Sheffield, England

Pub. Date: August 03, 2020

Cite this paper:
Kashini Andrew, Mohd Bakar and Mivanyi Kadala. Coronavirus Presenting With an Urticarial Rash: A Case Report and Literature Review. American Journal of Medical Case Reports. 2020; 8(11):431-432. doi: 10.12691/ajmcr-8-11-14


In December 2019 reports from Wuhan showed the emergence of a form of acute respiratory illness caused by a new strain of coronavirus subsequently named Severe acute respiratory distress syndrome coronavirus 2 (SARS CoV-2, 2019-nCoV) due to its close homology (80%) to SARS COV, responsible for a series of Acute Respiratory Distress syndrome between 2002-2003. Since the onset of the pandemic there has been an interest in the cutaneous manifestations of the viral infection. A 35 year old staff nurse presented with fever, dry cough, malaise and myalgia. She tested positive for SARS CoV2. She developed an urticarial rash which was red, itchy and macular affecting both forearms sparing the hands on day 10 of the onset of symptoms. The rash lasted for 72 hours and resolved spontaneously. She had not been started on any new medications prior to the onset of illness. She made a good recovery after three weeks of symptoms with itching controlled by chlorphenamine maleate. Physicians should remember that even though SARS-CoV2 presents with mainly respiratory symptoms which could become life threatening, cutaneous manifestations do occur and can vary in distribution and morphology.

coronavirus urticarial rash Wuhan

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review, Clinical Immunology (2019), Available online 20 April 2020, (cited 2020 April 28).
[2]  Recalcati S, Cutaneous manifestations in COVID19: a first perspective. J Eur Acad Dermatol Venereol. 2020 Mar 26. (Cited 2020 May 01).
[3]  Maurer M. and Grabbe J. Urticaria: Its History-Based Diagnosis and Etiologically Oriented Treatment Dtsch Arztebl Int. 2008 Jun; 105(25): 458-466.
[4]  Guan WJ, Ni ZY, Hu Y et al. Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med, 2020 Feb 28 (Cited 2020 May 02).
[5]  Manalo IF, Smith MK, Cheeley J, et al, A Dermatologic Manifestation of COVID-19: Transient Livedo Reticularis, Journal of the American Academy of Dermatology (2020).
[6]  Freeman EE, McMahon DE, Lipoff JB et al. The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries (2020) (Cited june 2020).